aid classic elispot plate reader (Cellular Technology Ltd)
Structured Review

Aid Classic Elispot Plate Reader, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 85 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+plate+reader/S6+Universal+M2/pmc12936837-401-18-23
Average 99 stars, based on 85 article reviews
Images
1) Product Images from "Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host"
Article Title: Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host
Journal: iScience
doi: 10.1016/j.isci.2026.114917
Figure Legend Snippet: Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo IFNγ-ELISpot well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Techniques Used: Generated, Infection, Ex Vivo, Enzyme-linked Immunospot, Control, Membrane, Comparison, Whisker Assay
Figure Legend Snippet: Failure of host T cells to recognize emerging virus (A) Ex vivo magnitude of the T cell response to individual ancestral sequence peptides in which mutation arose over persistent infection by IFNγ-ELISpot. (B) Magnitude of the CD4 and CD8 T cell responses after 10-day in vitro peptide expansion with individual ancestral sequence peptides. Percentage of CD4 and CD8 producing IFNγ, TNF, or both are shown. (C) Magnitude of IFNγ+, IFNγ+TNF+, and CTV lo IFNγ+ CD4 and CD8 T cells after 8-day expansion with a pool of 12 peptides corresponding to ancestral sequence epitopes or variant sequence epitopes containing mutations in the virus isolated at day 899 of infection. (D) Magnitude of the IFNγ+TNF+ CD4 or CD8 T cell response after 10-day in vitro peptide stimulation with individual epitopes using ancestral sequence or variant sequence peptides for culture and re-stimulation on day 9. Summary data showing all T cell responses that were detectable (left) or shown for individual peptides (right) for CD4 then CD8 T cells. Duplicate and triplicate stimulations are shown for CD8 T cells for M14 and NSP2, respectively. (D) Bars, mean. Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗∗ p ≤ 0.001. Peptide sequences shown in .
Techniques Used: Virus, Ex Vivo, Sequencing, Mutagenesis, Infection, Enzyme-linked Immunospot, In Vitro, Variant Assay, Isolation
Related Articles
Enzyme-linked Immunospot:Article Title: Development of a baculoviral CRISPR/Cas9 vector system for beta-2-microglobulin knockout in human pluripotent stem cells. Article Snippet: Cell therapy using derivatives of human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) represents one of the most promising therapeutic approaches in regenerative medicine.. However, the transplanted cells would probably be rejected due to a mismatch in human leukocyte antigen (HLA) between donor cells and recipient’s immune cells if hESCs and hiPSCs come from genetically unrelated individuals.. Even in an autologous transplantation setting that uses the terminally differentiated progeny of hiPSCs reprogrammed from the patient’s cells, reprogramming-associated genetic aberrations could enhance the immunogenicity of the differentiated cells (Zhao et al. 2011; Martins-Taylor and Xu 2012; Pearl et al. 2012; Fu 2014). Article Title: Single cell and TCR analysis of immune cells from AAV gene therapy-dosed Duchenne muscular dystrophy patients Article Snippet: The detection antibody was removed, and the plate was washed an additional five times with DPBS, and ready-to-use TMB substrate solution (100 μL/well) was added for the plate to develop within 5 min. TMB development was stopped by washing the plate extensively with sterile ddH 2 O (Thermo Fisher). .. After washing and drying, the spots were counted using an Article Title: Metabolic syndrome enhances SARS-CoV-2 disease severity and reduces mRNA vaccine efficacy in a mouse model Article Snippet: .. Foci were counted using an ImmunoSpot CTL Article Title: MAGE-A4 pMHC-targeted CAR-T cells exploiting TCR machinery exhibit significantly improved in vivo function while retaining antigen specificity. Article Snippet: After washing plates, spots were developed using streptavidin- alkaline phosphatase conjugated (Roche) and Sigmafast BICP/NBT (SigmaAldrich). .. Spots were counted using an Article Title: Cellular and humoral immune responses in cats vaccinated with feline herpesvirus 1 modified live virus vaccine Article Snippet: .. The spot-forming cells (SFCs) were counted using an Article Title: Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement Article Snippet: .. Plates were then left to dry and the spots were quantified using an Article Title: Lysosome-Associated Membrane Protein Targeting Strategy Improved Immunogenicity of Glycoprotein-Based DNA Vaccine for Marburg Virus Article Snippet: An HRP 3-amino-9-ethylcarbazole peroxidase substrate kit (Solarbio, Beijing, China) was used for chromogenic reactions. .. The spots were counted and analyzed by an Article Title: Construction and evaluation of glycoprotein-based nucleic acid vaccines for Marburg virus. Article Snippet: Marburg virus (MARV) is a zoonotic virus that can infect humans and non-human primates (NHPs) and lead to a fatal Marburg hemorrhagic fever (MHF) [1].. The virus is a single-stranded unsegmented negative strand RNA virus, belonging to the filoviridae family [2].. Discovered by German scientists in 1967, MARV has so far led to 16 sporadic outbreaks in Africa, Europe and other places, with a mean death rate of 88%. |

